CD8A and melanoma: Notably, we observed a robust increase in the number of infiltrated CD8+ T effector cells, but not other immune cells, in melanoma tumors doubly deficient in NACC1 and FKBP10, changes resembling those seen in NR2F6-ablated melanoma (Fig. 6, G and H, and fig.